Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
0.5800
-0.0440 (-7.05%)
At close: Sep 4, 2025, 4:00 PM
0.5390
-0.0410 (-7.07%)
Pre-market: Sep 5, 2025, 5:11 AM EDT
Incannex Healthcare Employees
Incannex Healthcare had 9 employees as of June 30, 2024. The number of employees increased by 6 or 200.00% compared to the previous year.
Employees
9
Change
6
Growth
200.00%
Revenue / Employee
$10,889
Profits / Employee
-$2,415,889
Market Cap
54.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 9 | 6 | 200.00% |
| Jun 30, 2021 | 3 | 1 | 50.00% |
| Jun 30, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IXHL News
- 9 days ago - Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder - GlobeNewsWire
- 13 days ago - Incannex Healthcare Authorizes $20 Million Share Repurchase Program - GlobeNewsWire
- 16 days ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update - Newsfile Corp
- 27 days ago - Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea - GlobeNewsWire
- 5 weeks ago - Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term - GlobeNewsWire
- 5 weeks ago - Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial - Benzinga
- 5 weeks ago - Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X - GlobeNewsWire
- 5 weeks ago - Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo - GlobeNewsWire